electroCore, Inc. (ECOR)
NASDAQ: ECOR · Real-Time Price · USD
6.25
+0.07 (1.13%)
At close: Apr 24, 2026, 4:00 PM EDT
6.18
-0.08 (-1.20%)
After-hours: Apr 24, 2026, 4:10 PM EDT
electroCore Revenue
In the year 2025, electroCore had annual revenue of $32.03M with 27.20% growth. electroCore had revenue of $9.24M in the quarter ending December 31, 2025, with 31.18% growth.
Revenue (ttm)
$32.03M
Revenue Growth
+27.20%
P/S Ratio
1.57
Revenue / Employee
$385,928
Employees
83
Market Cap
50.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.03M | 6.85M | 27.20% |
| Dec 31, 2024 | 25.18M | 9.15M | 57.09% |
| Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
| Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
| Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
| Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
| Dec 31, 2019 | 2.39M | 1.40M | 140.72% |
| Dec 31, 2018 | 992.95K | 181.50K | 22.37% |
| Dec 31, 2017 | 811.46K | 557.32K | 219.30% |
| Dec 31, 2016 | 254.14K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 118.37M |
| Pulmonx | 90.50M |
| Cytosorbents | 37.06M |
| Spectral AI | 19.65M |
| Elutia | 12.29M |
| NeuroOne Medical Technologies | 11.72M |
| Picard Medical | 4.94M |
ECOR News
- 1 day ago - electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation - GlobeNewsWire
- 16 days ago - electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 17 days ago - electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD - GlobeNewsWire
- 23 days ago - electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD - GlobeNewsWire
- 25 days ago - electroCore Expands Intellectual Property Portfolio - GlobeNewsWire
- 5 weeks ago - electroCore Announces Full Year 2025 Financial Results and Organizational Changes - GlobeNewsWire
- 6 weeks ago - electroCore to Participate at the 38th Annual Roth Conference - GlobeNewsWire
- 6 weeks ago - electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 - GlobeNewsWire